Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06127199 · ClinicalTrials.gov registry record · NA

Contraceptive Efficacy Study of Ovaprene

A NA study of Contraception, sponsored by Daré Bioscience.

Recruiting
Registry status
NA
Development phase
656
Enrollment target
20
Study locations

NCT06127199 is a NA study of Contraception that is actively recruiting participants, run by Daré Bioscience. The registered enrollment target is 656 participants, above the 446-participant average among 72 other Contraception trials with a reported enrollment target (47% higher). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06127199, a NA study of Contraception, is actively recruiting participants, sponsored by Daré Bioscience.

RECRUITING
Registry status
NA
Development phase
656 participants
Enrollment target
20
Study locations

Study Summary

This will be a multi-center, single arm, open-label study of Ovaprene, a non-hormonal intravaginal ring, to investigate the contraceptive effectiveness, safety and acceptability of Ovaprene.

Conditions Studied

Contraception

Interventions

  • DEVICE Ovaprene

Study Locations (20)

California

  • Essential Health Access (Berkeley) - Berkeley
  • Essential Access Health - Los Angeles
  • Amicis Research Center - Newhall
  • University of California at Davis - Sacramento
  • University of California, San Francisco - San Francisco

Arizona

  • Precision Trials AZ - Phoenix
  • MomDoc Women's Health Research - Scottsdale
  • Del Sol Research Management, LLC - Tucson

New York

  • Columbia University - New York
  • Einstein College of Medicine - The Bronx

Colorado

  • University of Colorado Denver - Aurora

Georgia

  • Emory University - Atlanta

Hawaii

  • University of Hawaii - Honolulu

Louisiana

  • Praetorian Pharmaceutical Research, LLC - Marrero

Maryland

  • The Johns Hopkins University - Baltimore

Trial Details

FieldValue
Enrollment Target 656 participants
Start Date 2023-12-19
Est. Completion 2026-09
Phase NA

Sponsor

Daré Bioscience

5 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06127199

The ClinicalTrials.gov registry entry for NCT06127199 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 656 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 446-participant average among 72 other Contraception trials with a reported enrollment target (47% higher). The listed sponsor is Daré Bioscience, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Contraception appearing as the primary indexed condition, and to 1 intervention - of which Ovaprene is the first listed.

NCT06127199 reports 20 study locations spanning 13 distinct geographic areas - top geographies include California, Arizona, New York.

Frequently Asked Questions

What is clinical trial NCT06127199 about?

NCT06127199 is a clinical study titled "Contraceptive Efficacy Study of Ovaprene". This will be a multi-center, single arm, open-label study of Ovaprene, a non-hormonal intravaginal ring, to investigate the contraceptive effectiveness, safety and acceptability of Ovaprene.

What is the current status of trial NCT06127199?

This trial is currently recruiting. It is a NA study. The enrollment target is 656 participants. The study started on 2023-12-19. Estimated completion is 2026-09.

What conditions does trial NCT06127199 study?

This clinical trial studies the following conditions: Contraception.

What interventions are being tested in trial NCT06127199?

The interventions under investigation include: Ovaprene (DEVICE).

Who is sponsoring clinical trial NCT06127199?

This trial is sponsored by Daré Bioscience, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06127199 being conducted?

This trial has 20 study locations across Arizona, California, Colorado, Georgia, Hawaii. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Contraception

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Contraception

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.